Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Havn Life Sciences Inc (HAVLF)

Havn Life Sciences Inc (HAVLF)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade HAVLF with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.2870 +10.28%
on 07/22/21
0.5230 -39.48%
on 06/24/21
-0.1935 (-37.94%)
since 06/23/21
3-Month
0.2870 +10.28%
on 07/22/21
0.6640 -52.33%
on 05/18/21
-0.2915 (-47.94%)
since 04/23/21

Most Recent Stories

More News
50+ Companies to Present at the Access to Giving Virtual Investor Conference on July 13th - 15th, 2021

an investor conference themed around investor education and advocacy begins next week, July 13 - 15, 2021. More than 50 companies are scheduled to conduct virtual presentations over the three-day period...

ACOG.VN : 0.950 (+18.75%)
ACER : 2.50 (+3.31%)
ADXN : 9.30 (-3.23%)
AGRX : 1.1600 (-4.13%)
ATGN : 2.3800 (+7.21%)
ABIO : 2.97 (-4.81%)
AUUD : 3.11 (-1.27%)
BASA : 0.3450 (-2.87%)
BMRA : 3.67 (-6.14%)
BKTI : 3.19 (-2.15%)
BSFC : 5.9900 (+76.18%)
DTST : 4.16 (-16.80%)
DCTH : 9.43 (-1.67%)
DMIFF : 0.2381 (-3.29%)
DLPN : 8.07 (-2.54%)
FLUX : 9.51 (-1.04%)
GBNH : 11.89 (-1.77%)
HAVLF : 0.3165 (+2.69%)
ISDR : 27.99 (-0.21%)
INLB : 2.8900 (+3.21%)
KNWN : 3.1500 (-3.96%)
LXXGF : 0.4210 (-0.05%)
MKTY : 7.28 (-2.02%)
MMATF : 13.6500 (-2.15%)
MRVFF : 1.0490 (-7.17%)
NEPH : 9.33 (+4.48%)
NMTC : 5.22 (-5.78%)
NLSP : 2.93 (-0.68%)
OBLG : 2.63 (+0.77%)
PBLA : 2.62 (-1.13%)
POSAF : 0.3938 (+2.98%)
PCSA : 7.00 (+1.45%)
PTIX : 2.46 (-0.40%)
QOEG : 0.1999 (-0.05%)
QIPT : 5.99 (-0.83%)
SNGX : 0.9646 (-1.97%)
STRR : 3.89 (+10.20%)
TGCB : 0.7000 (+16.65%)
VERB : 2.49 (+5.51%)
WTEQ.CN : 0.100 (+11.11%)
WINT : 1.8300 (-1.08%)
AYRO : 4.28 (-4.68%)
BCTX : 4.45 (+1.14%)
BTX : 10.26 (-14.78%)
HWAL : 1.7000 (-4.49%)
NMRD : 7.96 (+2.45%)
THBRF : 3.2900 (+1.86%)
TRIQ : 1.5500 (unch)
HAVN Life Signs Exclusive Supply Agreement With Cube Psytech

The Company will supply naturally-derived psilocybin for the development of psilocybin microdosing health products

HAVN.CN : 0.405 (+1.25%)
HAVLF : 0.3165 (+2.69%)
HAVN Life Sciences Signs Finished Goods Supply Agreement with Allied Health

The Agreement will utilize HAVN Life's fully integrated supply chain model, from the growing of psilocybin through to extraction, compounding, and encapsulation

HAVN.CN : 0.405 (+1.25%)
HAVLF : 0.3165 (+2.69%)
ALID : 1.1000 (-4.76%)
50+ Companies to Present at the Access to Giving Virtual Investor Conference on July 13th - 15th, 2021

an investor conference themed around investor education and advocacy is set for July 13-15, 2021. There will be 50+ companies conducting virtual presentations as well as private meetings with qualified...

ACOG.VN : 0.950 (+18.75%)
ACER : 2.50 (+3.31%)
ADXN : 9.30 (-3.23%)
AGRX : 1.1600 (-4.13%)
ATGN : 2.3800 (+7.21%)
ABIO : 2.97 (-4.81%)
AUUD : 3.11 (-1.27%)
BASA : 0.3450 (-2.87%)
BKTI : 3.19 (-2.15%)
BSFC : 5.9900 (+76.18%)
DTST : 4.16 (-16.80%)
DCTH : 9.43 (-1.67%)
DMIFF : 0.2381 (-3.29%)
DLPN : 8.07 (-2.54%)
FLUX : 9.51 (-1.04%)
GBNH : 11.89 (-1.77%)
HAVLF : 0.3165 (+2.69%)
ISDR : 27.99 (-0.21%)
INLB : 2.8900 (+3.21%)
KNWN : 3.1500 (-3.96%)
LXXGF : 0.4210 (-0.05%)
MKTY : 7.28 (-2.02%)
MMATF : 13.6500 (-2.15%)
MRVFF : 1.0490 (-7.17%)
NEPH : 9.33 (+4.48%)
NMTC : 5.22 (-5.78%)
NLSP : 2.93 (-0.68%)
OBLG : 2.63 (+0.77%)
PBLA : 2.62 (-1.13%)
POSAF : 0.3938 (+2.98%)
PCSA : 7.00 (+1.45%)
PTIX : 2.46 (-0.40%)
QOEG : 0.1999 (-0.05%)
QIPT : 5.99 (-0.83%)
SNGX : 0.9646 (-1.97%)
STRR : 3.89 (+10.20%)
TGCB : 0.7000 (+16.65%)
VERB : 2.49 (+5.51%)
WTEQ.CN : 0.100 (+11.11%)
WINT : 1.8300 (-1.08%)
HAVN Life Announces Retail Partnership with Grocer, Choices Markets

Newly-launched line of natural health products to be available at all locations later this month

HAVN.CN : 0.405 (+1.25%)
HAVLF : 0.3165 (+2.69%)
HAVN Life Launches New Line of Natural Health Products

Seven New Formulations That Support Brain Health and Immune Function Will Be Available Online and at Select Retail Locations Starting June 3

HAVN.CN : 0.405 (+1.25%)
HAVLF : 0.3165 (+2.69%)
HAVN Life Completes Acquisition of Clinical Stage IP for Development of Cluster Headache Drug

The Company will seek Orphan Drug Designation to significantly reduce time to market

HAVN.CN : 0.405 (+1.25%)
HAVLF : 0.3165 (+2.69%)
NIH Director Touted Benefits of Psychedelics Including Psilocybin and MDMA

Psychedelics may be one step closer to decriminalization. All after the Director of the National ...

CLXPF : 3.0000 (+1.01%)
MNMD : 3.07 (-2.23%)
HAVN.CN : 0.405 (+1.25%)
HAVLF : 0.3165 (+2.69%)
MYCOF : 0.3759 (-4.88%)
NMDBF : 0.1093 (-8.84%)
MYCO.CN : 0.470 (-5.05%)
NEON.CN : 0.140 (-6.67%)
Lobe Sciences Secures Production and Supply Agreement for Vitamind Consumer Packaged Goods Products

Vancouver, British Columbia--(Newsfile Corp. - May 19, 2021) - Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) ("" or the "") is pleased to announce it has entered into a production and supply agreement...

LOBE.CN : 0.090 (-10.00%)
GTSIF : 0.0740 (-4.64%)
HAVN.CN : 0.405 (+1.25%)
HAVLF : 0.3165 (+2.69%)
HAVN Life Secures Production & Supply Agreement to Expand Retail Product Offerings

Natural Health Products Will Be Manufactured and Packaged at the Company's New Facility

HAVN.CN : 0.405 (+1.25%)
HAVLF : 0.3165 (+2.69%)

Key Turning Points

3rd Resistance Point 0.3625
2nd Resistance Point 0.3467
1st Resistance Point 0.3316
Last Price 0.3165
1st Support Level 0.3007
2nd Support Level 0.2849
3rd Support Level 0.2698

See More

52-Week High 1.2500
Fibonacci 61.8% 0.8821
Fibonacci 50% 0.7685
Fibonacci 38.2% 0.6549
Last Price 0.3165
52-Week Low 0.2870

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar